Drug lookup
Drug reference

Doxepin

TCA · Antidepressant

Also known as Doxepin hydrochloride

TCAAntidepressant
CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
incl. contraindicated
PREGNANCY
not curated
Top interactionssee all 12
  • MoclobemideContraindicatedTextbookG&G 14e
  • AdrenalineSevereTextbookKDT 7e · p365
  • ArtemisininsSevereTextbookKDT 7e · p816-835
  • Meglumine AntimoniateSevereTextbookHarrison 22e · p1740

Mechanism

Doxepin, a tricyclic antidepressant, functions by blocking the re-uptake of both serotonin and noradrenaline in the brain, though to varying degrees. This action increases the concentration of these neurotransmitters in the synaptic cleft, enhancing mood. Doxepin also possesses significant sedative properties, making it particularly useful for agitated and anxious patients.

Indications

Depressive illness (particularly where sedation is required)depressionpsychotic depression (with first-generation antipsychotics)insomnia (low doses)pain conditionsSleep maintenance difficultiesInsomniapruritus control in Atopic Dermatitisimprove sleep in AD patients due to sedation

Dosing

Adult
BY MOUTH: Initially 75 mg daily in divided doses, alternatively 75 mg once daily, adjusted according to response, dose to taken at bedtime; maintenance 25–300 mg daily, doses above 100 mg given in 3 divided doses
Geriatric
Start with lower doses and adjust according to response. Elderly patients are particularly susceptible to many of the side-effects of tricyclic antidepressants; low initial doses should be used, with close monitoring, particularly for psychiatric and cardiac side-effects.
Max dose
300 mg daily

Pharmacokinetics

Half-life
18 hours (parent), 30 hours (active metabolite)
Metabolism
hepatic (CYP2D6, CYP2C19, CYP3A3/4, CYP1A2)

Contraindications

  • Acute porphyrias
  • during manic phase of bipolar disorder

Side effects

Common
AgitationAlopeciaAppetite decreasedAstheniaAsthma exacerbatedBreast enlargementGynaecomastiaHyperhidrosisHypertensionHypotensionIncreased risk of fractureLeucopeniaMood alteredMovement disordersNauseaNervousnessPhotosensitivity reactionSexual dysfunctionSkin reactionsSpeech disorderTesticular hypertrophyTremorUrinary hesitationVomitingWeight changesWithdrawal syndromesedationcognitive dullingblurred visiondry mouthtachycardiaconstipationdifficulty urinatingorthostatic hypotensionweight gainAbnormal thinking and behaviorWorsens suicidal ideation and depressionsedation (can become bothersome)
Serious
  • Agranulocytosis
  • Anticholinergic syndrome
  • Bone marrow depression
  • Cardiovascular effects
  • Hepatic disorders
  • Hyponatraemia
  • Paranoid delusions
  • Psychosis
  • Seizures
  • SIADH
  • Suicidal tendencies
  • Thrombocytopenia
  • quinidine-like effects on cardiac conduction (life threatening in overdose)
  • lowered seizure threshold
  • serotonin syndrome (with MAOIs)

Drug interactions

Moclobemide
Contraindicated
Textbook

Increased risk of serotonin syndrome and potentiated sympathomimetic effects.

Should not be used concurrently with MAOIs or within 14 days of stopping MAOIs.

Source: G&G 14e

Adrenaline
Severe
Textbook

Potentiation of adrenaline's effects.

Vasoconstrictor (adrenaline) containing LA should be avoided in patients receiving tricyclic antidepressants.

Source: KDT 7e · p365

Artemisinins
Severe
Textbook

Increased risk of cardiac conduction defects.

Source: KDT 7e · p816-835

Meglumine Antimoniate
Severe
Textbook

Increased cardiotoxicity (e.g., QT prolongation).

Source: Harrison 22e · p1740

Amiodarone
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amisulpride
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Anagrelide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Arbutamine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Arsenic Trioxide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Bedaquiline
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Bepridil
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Bupropion
Severe
Database

May increase plasma exposures of TCAs.

The possibility of drug interactions should be kept in mind until the safety of the combination is firmly established.

Source: DDInter

Related guidelines

Other TCA drugs

Ask House about Doxepin

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e, Harrison 22e, Katzung, BNF·Verified: 2026-05-10 · House clinical team